Updated on 2025/04/22

写真a

 
WATANABE Yu
 
Organization
Graduate School of Medicine Center for Research of Laboratory Animals and Medical Research Engineering Division for Advanced Medical Research Assistant Professor
Undergraduate School
School of Medicine Department of Medicine
Title
Assistant Professor

Degree 2

  1. 博士(医学) ( 2024.3   名古屋大学 ) 

  2. 学士(医学) ( 2014.3   名古屋大学 ) 

Research Interests 4

  1. 空間トランスクリプトーム

  2. ネフローゼ症候群

  3. マルチオミクス解析

  4. 腎臓学

Research Areas 2

  1. Life Science / Nephrology

  2. Life Science / Genome biology

Current Research Project and SDGs 1

  1. 難治性腎疾患の治療最適化

Research History 1

  1. Nagoya University   Graduate School of Medicine Center for Research of Laboratory Animals and Medical Research Engineering Division for Advanced Medical Research   Assistant Professor

    2025.4

Education 2

  1. Nagoya University

    2020.4 - 2024.3

  2. Nagoya University

    2008.4 - 2014.3

Professional Memberships 3

  1. 日本透析医学会

  2. 日本腎臓学会

  3. 日本内科学会

 

Papers 11

  1. Urinary presepsin can efficiently detect T-cell-mediated rejection in patients who have undergone kidney transplantation.

    Kawazoe T, Tanaka A, Furuhashi K, Hattori K, Onogi C, Owaki A, Kato A, Watanabe Y, Koshi-Ito E, Kato N, Kosugi T, Sano Y, Ishida S, Maruyama S

    Clinical and experimental nephrology     2025.4

     More details

    Language:English  

    DOI: 10.1007/s10157-025-02672-1

    PubMed

  2. Bone marrow niches orchestrate stem-cell hierarchy and immune tolerance.

    Furuhashi K, Kakiuchi M, Ueda R, Oda H, Ummarino S, Ebralidze AK, Bassal MA, Meng C, Sato T, Lyu J, Han MG, Maruyama S, Watanabe Y, Sawa Y, Kato D, Wake H, Reizis B, Frangos JA, Owens DM, Tenen DG, Ghiran IC, Robson SC, Fujisaki J

    Nature   Vol. 638 ( 8049 ) page: 206 - 215   2025.2

     More details

    Language:English  

    DOI: 10.1038/s41586-024-08352-6

    PubMed

  3. Association between alpha blocker use and the risk of fractures in patients with chronic kidney disease: a cohort study. Open Access

    Sunohara K, Onogi C, Tanaka A, Furuhashi K, Matsumoto J, Hattori K, Owaki A, Kato A, Kawazoe T, Watanabe Y, Koshi-Ito E, Maruyama S

    BMC nephrology   Vol. 25 ( 1 ) page: 442   2024.12

     More details

  4. Prognosis of microscopic polyangiitis is well predictable in the first 2 weeks of treatment. Open Access

    Owaki A, Tanaka A, Furuhashi K, Watanabe Y, Koshi-Ito E, Imaizumi T, Maruyama S

    Clinical and experimental nephrology   Vol. 28 ( 7 ) page: 701 - 706   2024.7

     More details

  5. Establishment of an adverse effect prevention protocol on plasma exchange using fresh frozen plasma prior to ABO-incompatible living donor kidney transplantation at our hospital.

    Tanaka A, Watanabe Y, Furuhashi K, Saito S, Yasuda Y, Kosugi T, Sano Y, Kato M, Maruyama S

    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy   Vol. 28 ( 1 ) page: 152 - 157   2024.2

     More details

    Language:English  

    DOI: 10.1111/1744-9987.14071

    PubMed

  6. Mortality and hyperkalaemia-associated hospitalisation in patients with chronic kidney disease: comparison of sodium zirconium cyclosilicate and sodium/calcium polystyrene sulfonate. Open Access

    Onogi C, Watanabe Y, Tanaka A, Furuhashi K, Maruyama S

    Clinical kidney journal   Vol. 17 ( 2 ) page: sfae021   2024.2

     More details

  7. Current status of low-density lipoprotein apheresis treatment for patients with peripheral artery disease and chronic kidney disease in Japanese clinical database.

    Watanabe Y, Tanaka A, Furuhashi K, Maruyama S

    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy   Vol. 27 ( 6 ) page: 1000 - 1009   2023.12

     More details

    Language:English  

    DOI: 10.1111/1744-9987.14046

    PubMed

  8. Prognosis and incidence of infections in chronic kidney disease patients with membranous nephropathy enrolled in a large Japanese clinical claims database. Open Access

    Matsuzaki T, Watanabe Y, Tanaka A, Furuhashi K, Saito S, Maruyama S

    BMC nephrology   Vol. 24 ( 1 ) page: 126   2023.5

     More details

  9. Long non-coding RNA lnc-CHAF1B-3 promotes renal interstitial fibrosis by regulating EMT-related genes in renal proximal tubular cells. Open Access

    Imai K, Ishimoto T, Doke T, Tsuboi T, Watanabe Y, Katsushima K, Suzuki M, Oishi H, Furuhashi K, Ito Y, Kondo Y, Maruyama S

    Molecular therapy. Nucleic acids   Vol. 31   page: 139 - 150   2023.3

     More details

  10. Systematic characterization of seed overlap microRNA cotargeting associated with lupus pathogenesis. Open Access

    Kitai H, Kato N, Ogami K, Komatsu S, Watanabe Y, Yoshino S, Koshi E, Tsubota S, Funahashi Y, Maeda T, Furuhashi K, Ishimoto T, Kosugi T, Maruyama S, Kadomatsu K, Suzuki HI

    BMC biology   Vol. 20 ( 1 ) page: 248   2022.11

     More details

  11. Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease and Sleep Apnea Syndrome. Open Access

    Watanabe Y, Tanaka A, Furuhashi K, Saito S, Maruyama S

    Frontiers in medicine   Vol. 9   page: 899359   2022

     More details

▼display all

Research Project for Joint Research, Competitive Funding, etc. 1

  1. 閉塞性動脈硬化症に対するLDL吸着療法が、慢性腎臓病患者の予後に与える影響のリアルワールドデータ解析

    2022.8 - 2023.3

    公益財団法人愛知腎臓財団  令和4年度研究助成金 

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\150000

KAKENHI (Grants-in-Aid for Scientific Research) 1

  1. 糸球体疾患における空間トランスクリプトームと病理所見の統合的解析

    Grant number:25K19485  2025.4 - 2027.3

    科学研究費助成事業  若手研究

    渡辺 裕

      More details

    Authorship:Principal investigator 

    Grant amount:\4810000 ( Direct Cost: \3700000 、 Indirect Cost:\1110000 )